123 related articles for article (PubMed ID: 33220903)
41. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
42. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
[TBL] [Abstract][Full Text] [Related]
43. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.
DeCoster RC; Lynch EB; Bonaroti AR; Miranda RN; Hunt KK; Clemens MW
Clin Plast Surg; 2021 Jan; 48(1):33-43. PubMed ID: 33220903
[TBL] [Abstract][Full Text] [Related]
44. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)].
Hedén P; Stark B
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175
[TBL] [Abstract][Full Text] [Related]
45. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
46. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Clinical Update.
Skelly A; Guo L
Ann Plast Surg; 2021 Mar; 86(3S Suppl 2):S154-S158. PubMed ID: 33346558
[TBL] [Abstract][Full Text] [Related]
47. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
48. Is breast implant-associated anaplastic large cell lymphoma a hazard of breast implant surgery?
Fitzal F; Turner SD; Kenner L
Open Biol; 2019 Apr; 9(4):190006. PubMed ID: 30939983
[TBL] [Abstract][Full Text] [Related]
49. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
[TBL] [Abstract][Full Text] [Related]
50. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
51. How to Diagnose and Treat Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Clemens MW; Brody GS; Mahabir RC; Miranda RN
Plast Reconstr Surg; 2018 Apr; 141(4):586e-599e. PubMed ID: 29595739
[TBL] [Abstract][Full Text] [Related]
52. Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Rastogi P; Deva AK; Prince HM
Curr Hematol Malig Rep; 2018 Dec; 13(6):516-524. PubMed ID: 30345474
[TBL] [Abstract][Full Text] [Related]
53. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
54. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
55. [Breast implant-associated anaplastic large-cell lymphoma].
Jarjis RD; Matzen SH
Ugeskr Laeger; 2015 Nov; 177(48):V07150625. PubMed ID: 26617170
[TBL] [Abstract][Full Text] [Related]
56. Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
Lukavsky RJ; Couto RA; Adams WP
Clin Plast Surg; 2021 Jan; 48(1):71-77. PubMed ID: 33220906
[TBL] [Abstract][Full Text] [Related]
57. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
O'Neill AC; Zhong T; Hofer SOP
Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
[TBL] [Abstract][Full Text] [Related]
58. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
59. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process.
Kim B; Roth C; Young VL; Chung KC; van Busum K; Schnyer C; Mattke S
Plast Reconstr Surg; 2011 Sep; 128(3):629-639. PubMed ID: 21502904
[TBL] [Abstract][Full Text] [Related]
60. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
